Edges in Network
| Network | GSE25065_top8000 - GSE25065 - SiGN-BN NNSR |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | ESR1 |
| Upstream (Parents) |
|---|
| (<<) TBC1D9 → ESR1 |
| (<<) XBP1 → ESR1 |
| Downstream (Children) |
|---|
| ESR1 → ERBB4 (>>) |
| ESR1 → THSD4 (>>) |
| ESR1 → VGLL1 (>>) |
| ESR1 → FABP7 (>>) |
| ESR1 → RARRES1 (>>) |
| ESR1 → CA12 (>>) |
| ESR1 → GREB1 (>>) |
| ESR1 → CYP2B7P1///CYP2B6 (>>) |
| ESR1 → CDH3 (>>) |
| ESR1 → PI3 (>>) |
| ESR1 → NAT1 (>>) |
| ESR1 → TBC1D9 (>>) |
| ESR1 → TTLL4 (>>) |
| ESR1 → PDZK1 (>>) |
| ESR1 → C6orf97 (>>) |
| ESR1 → CYP2B7P1 (>>) |
| ESR1 → ANG (>>) |
| ESR1 → EGFR (>>) |
| ESR1 → TPBG (>>) |
| ESR1 → BMPR1B (>>) |
| ESR1 → KCNK15 (>>) |
| ESR1 → IGF1R (>>) |
| ESR1 → GFRA1 (>>) |
| ESR1 → SLC39A6 (>>) |
| ESR1 → SMA4 (>>) |
| ESR1 → FBP1 (>>) |
| ESR1 → ATRNL1 (>>) |
| ESR1 → IQCH (>>) |
| ESR1 → SLC16A6 (>>) |
| ESR1 → NFATC4 (>>) |
| ESR1 → CEP290 (>>) |
| ESR1 → ACADSB (>>) |
| ESR1 → ENO1 (>>) |
| ESR1 → LAD1 (>>) |
| ESR1 → RARA (>>) |
| ESR1 → DCAF10 (>>) |
| ESR1 → CLSTN2 (>>) |
| ESR1 → GPR161 (>>) |
| ESR1 → PTK7 (>>) |
| ESR1 → C6orf211 (>>) |
| ESR1 → CCL20 (>>) |
| ESR1 → CCND1 (>>) |
| ESR1 → LRRC6 (>>) |
| ESR1 → C7orf63 (>>) |
| ESR1 → PHGDH (>>) |
| ESR1 → SYS1-DBNDD2///DBNDD2 (>>) |
| ESR1 → PSAT1 (>>) |
| ESR1 → ANKRD6 (>>) |
| ESR1 → RMND1 (>>) |
| ESR1 → MAP4K4 (>>) |
| ESR1 → CXADR (>>) |
| ESR1 → EVL (>>) |
| ESR1 → XBP1 (>>) |
